Noxopharm Limited
NOXOF · OTC
6/30/2024 | 12/30/2023 | 6/30/2023 | 12/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,080 | -$2,498 | -$9,630 | -$2,713 |
| Dep. & Amort. | $1 | $1 | $11 | $72 |
| Deferred Tax | $0 | $0 | -$272 | $0 |
| Stock-Based Comp. | $0 | $0 | $6 | $0 |
| Change in WC | $3,735 | $0 | $244 | $0 |
| Other Non-Cash | -$5,478 | $4,635 | $1,398 | $1,290 |
| Operating Cash Flow | -$2,822 | $2,138 | -$8,243 | -$1,352 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $124 | $0 |
| Investing Cash Flow | $0 | $0 | $124 | $12,552 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$10 | -$79 |
| Financing Cash Flow | $0 | $0 | -$20 | -$79 |
| Forex Effect | -$14 | $10 | -$2 | $1 |
| Net Chg. in Cash | -$1,418 | $1,074 | -$8,113 | $11,122 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $0 | $11,122 | $0 |
| End Cash | -$1,418 | $1,074 | $3,009 | $11,122 |
| Free Cash Flow | -$2,822 | $2,138 | -$8,243 | -$1,352 |